Bluefin Capital Management’s Gilead Sciences GILD Stock Holding History

Bluefin Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,000	Closed	-$4K	–	984
2021 Q3	$4K	Buy	+25,000	New	+$1.76M	﹤0.01%	700
2020 Q1	–	Sell	-18,000	Closed	-$3K	–	521
2019 Q4	$3K	Buy	+18,000	New	+$1.17M	﹤0.01%	564
2018 Q1	–	Sell	-32,700	Closed	-$2K	–	480
2017 Q4	$2K	Buy	+32,700	New	+$2.48M	﹤0.01%	456
2017 Q3	–	Sell	-15,300	Closed	-$10K	–	521
2017 Q2	$10K	Buy	+15,300	New	+$1.02M	﹤0.01%	455
2017 Q1	–	Sell	-10,700	Closed	-$1K	–	538
2016 Q4	$1K	Buy	+10,700	New	+$795K	﹤0.01%	522
2016 Q1	–	Sell	-248,800	Closed	-$2.62M	–	570
2015 Q4	$2.62M	Buy	+248,800	New	+$25.9M	0.21%	126
2015 Q3	–	Sell	-56,600	Closed	-$410K	–	535
2015 Q2	$410K	Buy	56,600 +5,700	+11%	+$623K	0.03%	318
2015 Q1	$462K	Sell	50,900 -122,300	-71%	-$12.4M	0.04%	272
2014 Q4	$763K	Sell	173,200 -21,700	-11%	-$2.24M	0.05%	296
2014 Q3	$697K	Buy	+194,900	New	+$19.1M	0.04%	353

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bluefin Capital Management's GILD Position: Q1 2026 in Review

Bluefin Capital Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 7,900 shares — an estimated $970K sold.

Bluefin Capital Management first reported a position in GILD in Q2 2013 and held it in 32 quarters. The position peaked at $21.7M in Q1 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Bluefin Capital Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Bluefin Capital Management sold 7,900 Gilead Sciences shares in Q1 2026, an estimated $970K.
Bluefin Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 32 quarters.
Bluefin Capital Management's Gilead Sciences position peaked at $21.7M in Q1 2015.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.